10 February 2017

Women initiated on anti-retroviral drugs based on how sick they are, are more likely to continue and adhere to treatment compared to those who are initiated bcause they are pregnant, a recent study on adherence of ARVs in pregnant woman has shown. Presenting study results in Harare yesterday, Clinton Health Access Initiative country director Mr Alexio Mangwiro said of the 1,150 women who took part in the study, 8,5 percent were lost to follow-up in the first three months.

Read the full article online here.